BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 1870266)

  • 1. [Production and secretion of the plasminogen activator inhibitor type-2 in a leukemia cell line].
    Niiya K
    Rinsho Ketsueki; 1991 May; 32(5):490-6. PubMed ID: 1870266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line.
    Niiya K; Takeuchi T; Kobayashi M; Miyoshi I; Hayashi T; Sakuragawa N
    Thromb Haemost; 1991 Aug; 66(2):232-8. PubMed ID: 1771617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
    Niiya K; Sakuragawa N
    Nihon Rinsho; 1992 Feb; 50(2):325-9. PubMed ID: 1319513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ; Sitrin RG
    J Immunol; 1990 Mar; 144(5):1873-9. PubMed ID: 2307845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR; Webb AC; Sitrin RG
    J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
    Niiya K; Taniguchi T; Shinbo M; Ishikawa T; Tazawa S; Hayakawa Y; Sakuragawa N
    Thromb Haemost; 1994 Jul; 72(1):92-7. PubMed ID: 7974383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the carboxy-terminal chain of plasminogen activators.
    Takeuchi T; Niiya K; Kubonishi I; Miyoshi I
    Thromb Haemost; 1990 Apr; 63(2):259-64. PubMed ID: 2363126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony stimulating factor and interleukin-3 regulate the production of an interleukin-1 inhibitor by the differentiated AML-193 leukemic cell line.
    Kindler V; Shields J; Ayer D; Benotto W; Mazzei GJ
    Eur Cytokine Netw; 1990; 1(3):169-76. PubMed ID: 2151793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the regulation of the plasminogen activator inhibitor-1 gene expression.
    Descheemaeker K
    Verh K Acad Geneeskd Belg; 1993; 55(3):225-64. PubMed ID: 8342330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".
    Nakamaki T; Hino K; Yokoyama A; Hisatake J; Tomoyasu S; Honma Y; Hozumi M; Tsuruoka N
    Anticancer Res; 1994; 14(3A):817-23. PubMed ID: 7521152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
    Schleef RR; Wagner NV; Loskutoff DJ
    J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human granulocyte-macrophage colony-stimulating factor plus phorbol myristate acetate stimulate a promyelocytic cell line to produce an IL-1 inhibitor.
    Mazzei GJ; Bernasconi LM; Lewis C; Mermod JJ; Kindler V; Shaw AR
    J Immunol; 1990 Jul; 145(2):585-91. PubMed ID: 2142181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
    Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
    Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
    Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive plasminogen activator inhibitor 1 (PAI-1) biosynthesis in human Hep G2 hepatoma cells is maintained by an autocrine factor.
    Bergonzelli GE; Kruithof EK
    Thromb Haemost; 1991 Aug; 66(2):222-5. PubMed ID: 1663279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines--evidence that the liver contributes to acute phase behaviour of PAI-1.
    de Boer JP; Abbink JJ; Brouwer MC; Meijer C; Roem D; Voorn GP; Lambers JW; van Mourik JA; Hack CE
    Thromb Haemost; 1991 Feb; 65(2):181-5. PubMed ID: 1711245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.